SLQT Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

0.924

Open

0.810

VWAP

0.88

Vol

1.44M

Mkt Cap

160.39M

Low

0.807

Amount

1.27M

EV/EBITDA(TTM)

12.86

Total Shares

176.29M

EV

803.96M

EV/OCF(TTM)

66.63

P/S(TTM)

0.11

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

Show More

Events Timeline

(ET)

2026-03-25

16:20:00

SelectQuote Faces NYSE Compliance Issue as Stock Price Falls Below $1

2026-01-15 (ET)

2026-01-15

07:10:00

SelectQuote Reaches New Agreement with Long-Time PBM Partner

2025-08-21 (ET)

2025-08-21

07:37:32

SelectQuote Announces Q4 EPS of 2 Cents, Below Consensus Estimate of 13 Cents

2025-07-02 (ET)

2025-07-02

16:16:03

SelectQuote vice chairman Tom Grant passes away

2025-05-12 (ET)

2025-05-12

07:36:04

SelectQuote sees FY25 revenue $1.5B-$1.575B, consensus $1.53B

2025-05-12

07:35:24

SelectQuote reports Q3 EPS 3c vs 5c last year

2025-05-09 (ET)

2025-05-09

08:04:34

SelectQuote responds to allegations in DOJ complaint

News

Newsfilter

04-21Newsfilter

SelectQuote to Release Q3 2026 Financial Results on May 5

Globenewswire

04-09Globenewswire

SelectQuote Executives Allegedly Breached Fiduciary Duties

Newsfilter

04-09Newsfilter

SelectQuote Executives Allegedly Breached Fiduciary Duties

seekingalpha

03-25seekingalpha

SelectQuote Faces Delisting Risk as Share Price Falls Below $1

PRnewswire

03-18PRnewswire

SelectQuote Executives Allegedly Breached Fiduciary Duties

Newsfilter

03-18Newsfilter

SelectQuote Executives Allegedly Breached Fiduciary Duties

3 Analyst Rating

Wall Street analysts forecast SLQT stock price to rise

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

5.00

Averages

6.00

High

7.00

Current: 0.000

Low

5.00

Averages

6.00

High

7.00

Noble Capital

Outperform

downgrade

$7 -> $5

AI Analysis

2026-02-06

Reason

Noble Capital

Price Target

$7 -> $5

AI Analysis

2026-02-06

downgrade

Outperform

Reason

Noble Capital lowered the firm's price target on SelectQuote to $5 from $7 and keeps an Outperform rating on the shares to reflect updated forecasts and heightened near-term uncertainty following the company's fiscal Q2 report.

Craig-Hallum

Buy

downgrade

$4 -> $3

2026-02-06

Reason

Craig-Hallum

Price Target

$4 -> $3

2026-02-06

downgrade

Buy

Reason

Craig-Hallum lowered the firm's price target on SelectQuote to $3 from $4 and keeps a Buy rating on the shares. The firm notes the company reported Q2 results that were modestly ahead of estimates but lowered the full year guide.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for SLQT

Unlock Now

Valuation Metrics

The current forward P/E ratio for SelectQuote Inc (SLQT.N) is 66.67, compared to its 5-year average forward P/E of -4.14. For a more detailed relative valuation and DCF analysis to assess SelectQuote Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-4.14

Current PE

66.67

Overvalued PE

36.80

Undervalued PE

-45.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

1.01

Current EV/EBITDA

2.20

Overvalued EV/EBITDA

53.39

Undervalued EV/EBITDA

-51.38

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.58

Current PS

0.08

Overvalued PS

1.42

Undervalued PS

-0.25

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

Intellectia · 40 candidates

Moving Average Relationship: PriceAboveMA20Month Price Change Pct: $0.00 - $20.00Is Index Component: GSPC, RUT, DJI, NDXOne Week Rise Prob: >= 60One Week Predict Return: >= 4.0%

Ticker

Name

Market Cap$

IDEXX Laboratories Inc

46.80B

Vera Therapeutics, Inc

3.03B

DocGo Inc

64.06M

SelectQuote Inc

137.12M

J&J Snack Foods Corp

1.53B

InfuSystem Holdings Inc

213.65M

Penny stocks that I should buy today

Intellectia · 20 candidates

Market Cap: 20.00M - 500.00MPrice: $0.05 - $1.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

Cue Biopharma Inc

49.02M

NUBURU Inc

29.84M

GameSquare Holdings Inc

35.43M

Gossamer Bio Inc

96.11M

Canaan Inc

303.68M

GoPro Inc

126.03M

lowest share costing stocks

Intellectia · 53 candidates

Market Cap: >= 50.00MRegion: USPrice: <= $1.00List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

KALA BIO Inc

195.30M

Mereo BioPharma Group PLC

55.83M

Sangamo Therapeutics Inc

130.65M

Ocean Power Technologies Inc

86.12M

Immutep Ltd

54.23M

Gossamer Bio Inc

89.54M

what should I buy under 1.00 a share?

Intellectia · 344 candidates

Price: $0.10 - $1.00List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

Alight Inc

507.72M

Wheels Up Experience Inc

406.86M

Standard BioTools Inc

392.26M

Getty Images Holdings Inc

360.43M

Beyond Meat Inc

352.61M

Canaan Inc

345.29M

Intellectia · 37 candidates

Market Cap: <= 300.00MPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Month Price Change Pct: >= $10.00

Ticker

Name

Market Cap$

Aspen Aerogels Inc

295.88M

SelectQuote Inc

283.31M

Shattuck Labs Inc

280.96M

Atea Pharmaceuticals Inc

275.01M

JELD-WEN Holding Inc

258.00M

Tigo Energy Inc

243.42M

good penny stocks to invest in

Intellectia · 32 candidates

Market Cap: <= 500.00MPrice: <= $5.00Quarter Revenue Yoy Growth: >= 10.0%Beta: HighRiskWeekly Average Turnover: >= 1,000,000

Ticker

Name

Market Cap$

Canaan Inc

498.64M

Organogenesis Holdings Inc

487.34M

Cerus Corp

485.98M

Ocugen Inc

465.36M

Agora Inc

402.42M

Nano Dimension Ltd

395.43M

Best stock under 3.50 that will 3x

Intellectia · 29 candidates

Market Cap: <= 2.00BPrice: <= $3.50Beta: HighRiskRevenue 5yr Cagr: >= 20Annual Eps Yoy Growth: >= 20.0%

Ticker

Name

Market Cap$

Clarivate PLC

1.86B

Bitfarms Ltd

1.61B

Blend Labs Inc

732.49M

SNDL Inc

406.85M

Lineage Cell Therapeutics Inc

382.34M

SelectQuote Inc

283.31M

Whales Holding SLQT

Abrams Bison Investments, L.L.C.

Trading Trends

People Also Watch

Frequently Asked Questions

What is SelectQuote Inc (SLQT) stock price today?

The current price of SLQT is 0.9098 USD — it has increased 8.6

What is SelectQuote Inc (SLQT)'s business?

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

What is the price predicton of SLQT Stock?

Wall Street analysts forecast SLQT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLQT is6.00 USD with a low forecast of 5.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SelectQuote Inc (SLQT)'s revenue for the last quarter?

SelectQuote Inc revenue for the last quarter amounts to 537.10M USD, increased 11.65

What is SelectQuote Inc (SLQT)'s earnings per share (EPS) for the last quarter?

SelectQuote Inc. EPS for the last quarter amounts to 0.27 USD, decreased -10.00

How many employees does SelectQuote Inc (SLQT). have?

SelectQuote Inc (SLQT) has 1181 emplpoyees as of April 27 2026.

What is SelectQuote Inc (SLQT) market cap?

Today SLQT has the market capitalization of 160.39M USD.